Keywords: dupont, merck, gains, rights, leo, innohep, obtained
DuPont Merck Gains US Rights To Leo's Innohep
Article | 02 April 1998
DuPont Merck has obtained US rights to Leo Pharmaceuticals'low-molecular weight heparin Innohep (tinzaparin). DuPont Merck plans to file a New ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
